Extending Life in Refractory Cancer: The Trifluridine and Tipiracil Tablet Market
The Trifluridine and Tipiracil Tablet Market is seeing sustained growth as it becomes a cornerstone of third- and fourth-line therapy for gastrointestinal malignancies. In an era of high-cost IV biologics, this oral chemotherapy combination offers a crucial balance of efficacy and patient … Read more